FDA aprova o primeiro tratamento injetável para profilaxia pré-exposição ao HIV.
10 Jan, 2022 | 12:09hComentários:
NIH celebrates FDA approval of long-acting injectable drug for HIV prevention – NIH News Releases
A new injection to prevent HIV, rather than pills, is a game-changer, scientists say – NPR
Conteúdos relacionados:
CDC Guidance: Preexposure Prophylaxis for Prevention of HIV Acquisition Among Adolescents
USPSTF Statement: Preexposure Prophylaxis for the Prevention of HIV Infection
British Guidelines on the Use of HIV Pre–exposure Prophylaxis (PrEP) (várias diretrizes sobre o tema)
New Protocol for HIV Prevention Drug Reduces The Number Of Pills Required